Scientists devise a barcode for the bacteria that causes tuberculosis

Doctors and researchers will be able to easily identify different types of tuberculosis (TB) thanks to a new genetic barcode devised by scientists from the School September 1, 2014 The bacteria that cause the deadly respiratory disease have evolved into families of strains, or lineages, which may affect people differently. To help identify the different origins and map how tuberculosis …

MBio Diagnostics Presents Tuberculosis Study Results

MBio Diagnostics presents “Highly Multiplexed Detection of Antibodies in Whole Blood during Tuberculosis Infection” study results. March 11, 2014 MBio Diagnostics, Inc. presented results last week of a study entitled “Highly Multiplexed Detection of Antibodies in Whole Blood during Tuberculosis Infection” at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, MA. MBio is collaborating with the Foundation for …

Prevention of TB infection study underway in South Africa

Novel Vaccine Trial Design Aims to Answer Key Tuberculosis Questions and Enhance Vaccine Development Strategy. March 11, 2013 Statens Serum Institut and Aeras today announced the initiation of the first randomized, controlled tuberculosis (TB) vaccine trial designed to study prevention of Mycobacterium tuberculosis (Mtb) infection by vaccination. The Phase II study of the TB vaccine candidate, H4+IC31® (AERAS-404), will evaluate …

2020 vision for vaccines against HIV, tuberculosis and malaria

Rino Rappuoli, PhD, is Global Head of Vaccines Research at Novartis Vaccines and Diagnostics and is based in Siena, Italy.   In one of his most recent publications in Nature together with Alan Aderem, they discuss their 2020 vision for vaccines against HIV, tuberculosis and malaria.   Acquired immune deficiency syndrome (AIDS), malaria and tuberculosis collectively cause more than five …